Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00414921 · ClinicalTrials.gov registry record · Phase 2
Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)
A Phase 2 study of Attention Deficit Hyperactivity Disorder, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT00414921 is a Phase 2 study of Attention Deficit Hyperactivity Disorder that has completed, run by University of Cincinnati. The registered enrollment target is 30 participants, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00414921, a Phase 2 study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and efficacy of two medications--clonidine and methylphenidate--alone or in combination to treat attention deficit hyperactivity disorder in children ages 4 through 6.
Conditions Studied
Interventions
- OTHER placebo
- DRUG clonidine
- DRUG methylphenidate
Study Locations (3)
New York
- University of Rochester Medical Center, Department of Neurology, 919 Westfall Road, Building C - Rochester
Ohio
- University of Cincinnati, Department of Psychiatry, 231 Albert Sabin Way, M: 0559 - Cincinnati
Pennsylvania
- Western Psychiatric Institute and Clinic, ADD Program, 3811 Ohara Street - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-09 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00414921
The ClinicalTrials.gov registry entry for NCT00414921 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (85% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.
NCT00414921 reports 3 study locations spanning 3 distinct geographic areas - top geographies include New York, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00414921 about?
NCT00414921 is a clinical study titled "Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)". The purpose of this study is to evaluate the safety and efficacy of two medications--clonidine and methylphenidate--alone or in combination to treat attention deficit hyperactivity disorder in children ages 4 through 6.
What is the current status of trial NCT00414921?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2003-09. Estimated completion is 2007-06.
What conditions does trial NCT00414921 study?
This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.
What interventions are being tested in trial NCT00414921?
The interventions under investigation include: placebo (OTHER), clonidine (DRUG), methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00414921?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00414921 being conducted?
This trial has 3 study locations across New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMT Inhibition Among Individuals With Comorbid AUD/ADHD
RECRUITING · Phase 2
-
Acute Effects of Stimulant Medication in College Students With ADHD
RECRUITING · Phase 2
-
Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
COMPLETED · Phase 2
-
Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
COMPLETED · Phase 2
-
Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
COMPLETED · Phase 2
-
A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.